A phase I trial of topical Radezolid for the treatment of mild-to-moderate acne vulgaris.

Trial Profile

A phase I trial of topical Radezolid for the treatment of mild-to-moderate acne vulgaris.

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Oct 2017

At a glance

  • Drugs Radezolid (Primary)
  • Indications Acne vulgaris
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Oct 2017 According to a Melinta Therapeutics media release, radezolid was well tolerated with minimal systemic absorption.
    • 10 Oct 2017 Status changed from recruiting to completed, according to Melinta Therapeutics media release.
    • 09 Aug 2017 According to Cempra Pharmaceuticals media release, this trial is nearing completion.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top